
Endometriosis or Inflammatory Bowel Disease? The Key Differences
How to tell them apart, where they overlap, and what the evidence says about a connection

Distinguishing the Differences
Exploring the complex world of health and medical conditions can sometimes feel like navigating a labyrinth. The similarities between certain conditions often blur the lines, making it challenging for individuals and even healthcare professionals to differentiate between them. This is notably true when comparing endometriosis and inflammatory bowel disease (IBD), two disorders that share several overlapping symptoms and characteristics. With ongoing conversations about endometriosis and its impact on the bowel, this article aims to clarify the differences, similarities, and diagnostic challenges associated with these conditions.
Symptoms of Endometriosis
The signs and symptoms of endometriosis can vary greatly, making it a complex disease to diagnose. Common symptoms include dysmenorrhea (painful periods), dyspareunia (painful intercourse), chronic pelvic pain, and gastrointestinal symptoms such as diarrhea, constipation, and abdominal pain. Because endometriosis symptoms often overlap with gastrointestinal complaints, getting a diagnosis can be tricky—especially when the bowels may be involved, which is estimated in about 5–12% of cases. Approximately 90% of those with endometriosis experience gastrointestinal symptoms. In many cases, these symptoms are mistaken for other conditions, leading to delays in diagnosis.
Inflammatory Bowel Disease: An Overview
Inflammatory bowel disease (IBD) is an umbrella term for two chronic autoimmune disorders: ulcerative colitis (UC) and Crohn’s disease (CD). These conditions are characterized by chronic inflammation of the gastrointestinal tract and can cause a wide range of symptoms, including abdominal pain, diarrhea, weight loss, and fatigue.
The prevalence of IBD is highest in Europe, with reported cases reaching up to 505 per 100,000 for UC in Norway and 322 per 100,000 for CD in Italy. Like endometriosis, IBD can significantly impact quality of life and often requires long-term management strategies to control symptoms and prevent complications.
The Overlap: Endometriosis and IBD
Endometriosis and IBD share several common traits, including immune dysregulation and overlapping clinical manifestations such as abdominal pain and bowel-related symptoms. This overlap poses a significant diagnostic challenge because endometriosis can mimic IBD and vice versa, leading to delays or indeterminate diagnoses.
Endometriosis is often described as having “IBD-like” features due to similarities in symptoms and aspects of underlying pathophysiology. This has prompted substantial interest in a potential link between the conditions, with multiple studies investigating their co-occurrence.
Investigating the Link: Endometriosis and IBD
To better understand the potential connection between endometriosis and IBD, numerous studies have explored the topic, ranging from case reports and clinical series to epidemiological investigations. Findings vary, underscoring the complexity of these conditions and the difficulties inherent in diagnosis and management.
Case Reports and Clinical Series
Multiple case reports highlight the diagnostic challenges associated with endometriosis and IBD. Several cases initially diagnosed as Crohn’s disease were later revised to intestinal endometriosis upon histopathological examination. Other reports have documented instances where an initial diagnosis of ulcerative colitis was later confirmed to be appendiceal endometriosis.
Conversely, there have been cases where an initial diagnosis of endometriosis was later revised to Crohn’s disease on histopathology. Additional reports describe patients diagnosed with both Crohn’s disease and endometriosis.
Struggling to Differentiate Symptoms?
Our specialists are here to help you understand your condition and explore your treatment options.
Schedule Your ConsultationEpidemiological Studies
Beyond case-based literature, epidemiological studies have examined the co-occurrence of endometriosis and IBD. A nationwide Danish cohort study reported a 50% increase in the risk of IBD among women with endometriosis compared to the general population. This elevated risk persisted more than 20 years after an endometriosis diagnosis, suggesting a genuine association.
A retrospective cross-sectional study in Israel found that 2.5% of patients with endometriosis also had IBD, compared to 1% in the general population. A recent Italian case-control study reported that among 148 women with endometriosis, five had IBD, although this finding did not reach statistical significance.
The Challenge of Temporality
A key issue in evaluating the association between endometriosis and IBD is temporality—the order in which diagnoses occur. Many studies do not report whether endometriosis or IBD came first, making it difficult to assess causality.
Complicating matters further, endometriosis is frequently diagnosed after significant delays. On average, there is a seven-year gap between symptom onset and definitive diagnosis. This delay makes it even harder to determine the temporal relationship between endometriosis and IBD.
Distinguishing Between Endometriosis and IBD
Given the overlapping symptoms and shared characteristics, distinguishing between endometriosis and IBD can be challenging. Both conditions can produce abdominal pain and bowel-related symptoms, contributing to misdiagnosis or delayed diagnosis.
When endometriosis and IBD coexist, symptoms may be atypical and cyclic. Fibrosis resulting from chronic inflammation can lead to obstruction of the intestinal lumen. For these reasons, healthcare professionals should consider both conditions when evaluating patients with relevant symptoms.
In cases of intestinal endometriosis, endoscopic biopsies may reveal IBD-like lesions. However, these lesions may be an epiphenomenon of endometriosis rather than true IBD. Patients with concurrent IBD and endometriosis should be followed over time to reassess the IBD diagnosis as needed.
The Role of Treatment in the Risk of IBD
Treatment for endometriosis could potentially influence the risk of developing IBD. Oral contraceptives are commonly used for endometriosis management, and a meta-analysis of 14 studies suggested an increased risk of IBD among oral contraceptive users. Non-steroidal anti-inflammatory drugs (NSAIDs), often used for pain relief in endometriosis, have also been reported to increase IBD risk.
The Need for Further Research
Existing research has illuminated aspects of the association between endometriosis and IBD, but significant questions remain. Further studies are needed to clarify the temporal relationship when both conditions occur together and to identify predictors that could guide evaluation and management.
A deeper understanding of these conditions and their potential links can improve diagnostic accuracy, inform treatment strategies, and enhance quality of life for those affected. While distinguishing between endometriosis and IBD can be challenging due to overlapping features, recognizing the nuances and emerging evidence offers a path toward better outcomes as research progresses.
References
Parazzini F, Luchini L, Vezzoli F, Mezzanotte C, Vercellini P. Gruppo italiano perlo studio dell’endometriosi. Prevalence and anatomical distribution of endometriosisin women with selected gynaecological conditions: results from amulticentric Italian study. Hum Reprod 1994;9:1158–62. https://pubmed.ncbi.nlm.nih.gov/7962393/
Bulun SE. Endometriosis. N Engl J Med 2009;360:268–79. DOI: 10.1016/j.euros.2025.10.003
Weed JC, Ray JE. Endometriosis of the bowel. Obstet Gynecol 1987;69:727–30. DOI: 10.1016/j.ejrad.2023.110730
Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012;142:46–54. DOI: 10.1053/j.gastro.2021.12.282
Nielsen NM, Jorgensen KT, Pedersen BV, Rostgaard K, Frisch M. The co-occurrence of endometriosis with multiple sclerosis, systemic lupus erythematosus and Sjogren syndrome. Hum Reprod 2011;26:1555–9. DOI: 10.1093/humrep/der105
Quick Answers
How rare is endosalpingiosis?
Endosalpingiosis is generally considered uncommon, but “how rare” it is depends heavily on who’s being studied and how it’s found. Many cases are discovered incidentally on pathology—meaning tissue is identified under the microscope after surgery done for other reasons—so it’s likely underrecognized in the general population. In other settings (like surgical cohorts), it may appear more often simply because more tissue is being sampled and examined carefully.
What matters most for patients is that endosalpingiosis can be confused with endometriosis on imaging or even at surgery, yet it doesn’t always behave the same way clinically. If you’ve been told you have endosalpingiosis and you also have pelvic pain, bowel/bladder symptoms, or fertility concerns, our team can help interpret what that finding means in the context of your symptoms and operative/pathology reports. You’re welcome to explore our educational content on related endometriosis and uterine conditions, and reach out to schedule a consultation if you want a personalized plan.
Can endometriosis cause a painful bump near the anus?
Yes. Endometriosis can contribute to pain and pressure around the rectum and anal area, especially when disease involves the rectum/rectosigmoid region or nearby tissues. Many patients describe deep pain with bowel movements, rectal pressure, or symptoms that flare around their cycle, and those patterns can fit bowel or deep infiltrating endometriosis.
That said, a sensitive bump on the anus itself is more often something else (like a hemorrhoid, fissure, skin infection/abscess, or another localized anal/skin condition). In some cases, pelvic disease can coexist with these issues, which is why we don’t assume every finding is endometriosis—or dismiss it as “nothing.”
If you’re noticing a new, persistent, or worsening bump—especially if it’s very tender, draining, bleeding, or associated with fever—we want to evaluate the full picture. Our team can sort out whether your symptoms point toward bowel endometriosis, a separate anorectal condition, or both, and plan next steps such as a focused exam and, when appropriate, expertly interpreted imaging to map possible deep disease.
When is menstrual bleeding considered too heavy?
Menstrual flow is generally “too heavy” when it consistently disrupts your life or overwhelms your usual period products—think flooding or soaking through pads/tampons quickly, passing frequent or large clots, needing to double up, or bleeding long enough that you can’t plan around it. Another major clue is fatigue, dizziness, or shortness of breath that can come with iron deficiency from ongoing blood loss. If you’re timing your day around bathrooms, waking at night to change products, or avoiding work, exercise, travel, or sex because of bleeding, that’s not something we consider “normal.”
Heavy bleeding is a symptom, not a diagnosis, and common underlying drivers include adenomyosis, fibroids, hormonal imbalance, and sometimes endometriosis—especially when heavy bleeding shows up with severe cramps or deep pelvic pain. Because imaging and symptoms don’t always match (a scan can look “mild” while symptoms are intense), we take a symptom-led approach and look at the full pattern, including pain, pressure, clots, cycle timing, and any signs of anemia. If your bleeding feels like it’s escalating or you’ve been told to “just live with it,” our team can help you sort out likely causes and build a plan that targets the source—not just the bleeding.
What is the Enzian score for endometriosis?
The Enzian score is a detailed way clinicians describe where deep infiltrating endometriosis (DIE) is located and how extensive it is. Unlike simple “stage” systems, Enzian focuses on endometriosis that grows into deeper tissues and can involve structures like the uterosacral ligaments, rectovaginal area, bowel, bladder, and ureters—areas that often drive bowel, urinary, or deep pain symptoms.
In practical terms, an Enzian classification helps your surgical team communicate the anatomic pattern of disease and plan the right imaging, operative approach, and multidisciplinary support when organs may be involved. It’s also a reminder that symptom severity doesn’t always match what’s seen on exam or imaging—deep disease can be easy to miss without a targeted evaluation. If you’ve been told your findings are “mild” but your symptoms suggest deeper involvement, our team can help interpret prior reports and discuss what an Enzian-style mapping and excision-focused plan could look like.
How long does endo belly (bloating) usually last?
“Endo belly” can last anywhere from a few hours to several days, and for some people it can linger longer or feel nearly constant during certain parts of the month. The duration often depends on what’s driving it for you—hormone-linked inflammation around ovulation or a period, bowel slowing/constipation, pelvic adhesions restricting organ movement, or a combination. Many patients notice it waxes and wanes, sometimes changing noticeably within the same day.
If your bloating is predictable and cyclical, that pattern can be a clue that endometriosis or adenomyosis-related inflammation is playing a major role—even when imaging looks “normal.” If it’s frequent, severe, or paired with bowel or bladder symptoms (pain with bowel movements, urinary urgency, rectal pressure), it can also suggest deeper pelvic disease or significant inflammation affecting nearby organs. Our team can help you sort out whether your “endo belly” is primarily hormonal, GI-driven, or related to pelvic disease that may benefit from targeted treatment, including excision when appropriate—reach out to schedule a consultation and we’ll map your symptoms to a clear plan.

